Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children

Pediatric Nephrology

Volumn 22, Issue 4, 2007, Pages 496-502

  Fine, Richard N ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Immunosuppressive medications; Long term outcome; Nephrectomy; Plasmapheresis; Recurrent focal segmental glomerulosclerosis (FSGS)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; PODOCIN; POLYCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADJUVANT THERAPY; AFRICAN AMERICAN; ARTICLE; DISEASE COURSE; DONOR SELECTION; DRUG BIOAVAILABILITY; DRUG MEGADOSE; ETHNIC DIFFERENCE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GRAFT FAILURE; GRAFT SURVIVAL; HETEROZYGOTE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LIVING DONOR; NEPHRECTOMY; NEPHROTIC SYNDROME; ONSET AGE; PLASMAPHERESIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REMISSION; RETRANSPLANTATION; RISK FACTOR; SURVIVAL RATE;

CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; NEPHROTIC SYNDROME; RECURRENCE; RISK FACTORS;

EID: 33847355663     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0361-6     Document Type: Article

References (40)

1. NAPRTCS 2004 Annual Report. Available online at https://web.emmes.com/ study/ped/annlrept/annlrept2004.pdf
2. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF (1972) Recurrence of idiopathic nephrotic syndrome after renal transplantation. 1972. Lancet 2:343-348
3. (1972) Focal glomerulosclerosis. Lancet 2:367
4. Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2(12 Suppl):S258-S263
5. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR (2001) Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 59:328-333
6. Jungraithmayr T, Clara A, Zimmerhackl L (2005) Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation: Results of the European Collaborative FSGS transplantation study group (ECOFTS). Pediatr Transplant Suppl 6:48
7. Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ (2005) Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 5:2907-2912
8. Kerjaschki D (2001) Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 108:1583-1587
9. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, Sanna-Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314-1321
10. Caridi G, Perfumo F, Ghiggeri GM (2005) NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57:54R-61R
11. Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int 67:987-1001
12. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393-397
13. Baqi N, Tejani A (1997) Recurrence of the original disease in pediatric renal transplantation. J Nephrol 10:85-92
14. Bartosh SM, Stablein DM, Fine RN (2004) Recurrence of focal segmental glomerulosclerosis (FSGS) following pediatric kidney transplantation in the modern immunosuppression era: A report from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Submitted for presentation at the American Transplant Congress, Boston, Massachusetts, 15-19 May 2004
15. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883
16. Raafat R, Travis LB, Kalia A, Diven S (2000) Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 14:189-194
17. Gagnadoux MF (2002) Ask the expert. Does antibody induction therapy with daclizumab or basiliximab increase the risk of recurrence of post-transplant focal segmental glomerulosclerosis? Pediatr Nephrol 17:305
18. Sheth RD, Kale AS, Goldstein SL, Brewer ED (2001) Rapid recurrence of post-transplant FSGS in pediatric patients after daclizumab induction. Pediatr Nephrol 16:C190
19. Hubsch H, Montane B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G (2005) Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 20:210-216
20. Odorico JS, Knechtle SJ, Rayhill SC, Pirsch JD, D'Alessandro AM, Belzer FO, Sollinger HW (1996) The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61:228-234
21. Baum MA, Ho M, Stablein D, Alexander SR; North American Pediatric Renal Transplant Cooperative Study (2002) Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 6:488-492
22. Huang K, Ferris ME, Andreoni KA, Gipson DS (2004) The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Am J Kidney Dis 43:1082-1090
23. Schachter AD, Harmon WE (2001) Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 5:406-409
24. Sweet SC, Wong HH, Webber SA, Horslen S, Guidinger MK, Fine RN, Magee JC (2006) Pediatric transplantation in the United States, 1995-2004. Am J Transplant 6:1132-1152
25. Cameron JS, Senguttuvan P, Hartley B, Rigden SP, Chantler C, Koffman G, Williams DG, Ogg CS (1989) Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 21:2117-2118
26. Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, Williams DG, Ogg C, Koffman G (1990) Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4:21-28
27. First MR (1995) Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol 9(Suppl):S40-S42
28. Winn MP, Alkhunaizi AM, Bennett WM, Garber RL, Howell DN, Butterly DW, Conlon PJ (1999) Focal segmental glomerulosclerosis: A need for caution in live-related renal transplantation. Am J Kidney Dis 33:970-974
29. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15:722-732
30. Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66:571-579
31. Ismail-Allouch M, Burke G, Nery J, Roth D, Esquenazi V, Ruiz P, Miller J (1993) Rapidly progressive focal segmental glomerulosclerosis occurring in a living related kidney transplant donor: Case report and review of 21 cases of kidney transplants for primary FSGS. Transplant Proc 25:2176-2177
32. Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN (1988) Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 46:540-542
33. Ingulli E, Tejani A, Butt KM, Rajpoot D, Gonzalez R, Pomrantz A, Ettenger R (1990) High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation. Transplantation 49:219-221
34. Raafat RH, Kalia A, Travis LB, Diven SC (2004) High-dose oral cyclosporine therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 44:50-56
35. Cochat P, Kassir A, Colon S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L (1993) Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 7:50-54
36. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14
37. Salomon R, Gagnadoux MF, Niaudet P (2003) Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 27:810-814
38. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K (2001) Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 71:628-633
39. Rianthavorn P, Bhakta N, Gjertson D, Ettenger R (2005) A coherent approach to recurrent focal segmental glomerulosclerosis in children? The effects of high dose cyclosporine and pretransplant plasmapheresis. Pediatr Transplant Suppl 6:48
40. Kawamura T, Motoyama O, Aikawa A, Ohara T, Motoyama O, Hasegawa A (2005) Outcome of first living related renal transplantation for pediatric patients with focal segmental glomerulonephritis in Japan - a single center experience. Pediatr Transplant Suppl 6:59-60